Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Fierce Pharma
Obesity meds, China drive $2T in projected 2032 drug sales: report
Together, drugs tackling obesity and inflammatory conditions are expected to push global pharmaceutical sales above $2 trillion in 2032, per Evaluate.
Fraiser Kansteiner
Jun 23, 2026 9:00am
In another reversal, FDA to reconsider Regenxbio gene therapy
Jun 22, 2026 10:26am
FDA appears less prickly toward Moderna mRNA flu shot
Jun 16, 2026 2:46pm
Fierce Pharma
Biopharma rallies behind Pazdur to lead FDA. But is he willing?
May 14, 2026 11:05am
Fierce Pharma
FDA's embattled Marty Makary steps down as commissioner
May 12, 2026 2:30pm
FDA demands ph. 3 trial of uniQure's Huntington's gene therapy
Mar 2, 2026 10:45am